Stay updated on Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Sign up to get notified when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.

Latest updates to the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer page revision.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status updated to indicate no longer recruiting participants. The change communicates that enrollment for this study is closed and no further participants will be enrolled.SummaryDifference0.5%

- Check25 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5. This represents a minor update to the page's metadata rather than substantive content changes.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation/version.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page footer revision label was updated to version v3.5.3 instead of v3.5.2, indicating a small system/content-management release without changing the study record details.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.